Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Cerus Corp (CERS)

Cerus Corp (CERS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2400 -0.0500 (-3.88%) 04/04/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2016 -0.0384 (-3.10%) 16:51 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.1900
Day High
1.2800
Open 1.2500
Previous Close 1.2900 1.2900
Volume 1,655,600 1,655,600
Avg Vol 1,492,845 1,492,845
Stochastic %K 17.50% 17.50%
Weighted Alpha -44.47 -44.47
5-Day Change -0.1800 (-12.68%) -0.1800 (-12.68%)
52-Week Range 1.1900 - 2.5400 1.1900 - 2.5400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 239,669
  • Shares Outstanding, K 185,790
  • Annual Sales, $ 201,320 K
  • Annual Income, $ -20,920 K
  • EBIT $ -14 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.70
  • Price/Sales 1.44
  • Price/Cash Flow N/A
  • Price/Book 4.57

Options Overview Details

View History
  • Implied Volatility 351.20% ( -17.41%)
  • Historical Volatility 53.61%
  • IV Percentile 99%
  • IV Rank 95.09%
  • IV High 368.61% on 04/03/25
  • IV Low 13.90% on 07/08/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 124
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 6,371
  • Open Int (30-Day) 7,206

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.05
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1900 +4.20%
on 04/04/25
Period Open: 1.5800
1.6300 -23.93%
on 03/05/25
-0.3400 (-21.52%)
since 03/04/25
3-Month
1.1900 +4.20%
on 04/04/25
Period Open: 1.6800
2.2350 -44.52%
on 01/28/25
-0.4400 (-26.19%)
since 01/03/25
52-Week
1.1900 +4.20%
on 04/04/25
Period Open: 1.8900
2.5400 -51.18%
on 08/02/24
-0.6500 (-34.39%)
since 04/04/24

Most Recent Stories

More News
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Insider Sale: Director at $CERS (CERS) Sells 20,000 Shares

ERIC BJERKHOLT, a director at $CERS ($CERS), sold 20,000 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.0% of their shares....

CERS : 1.2400 (-3.88%)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cerus: Q2 Earnings Snapshot

Cerus: Q2 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cerus: Q1 Earnings Snapshot

Cerus: Q1 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor keeps making moves.

^BTCUSD : 83,744.16 (-0.48%)
^BTCUSDT : 83,754.62 (-0.48%)
TSLA : 239.43 (-10.42%)
ARKB : 83.77 (+2.46%)
CERS : 1.2400 (-3.88%)
3 Growth Stocks That Could Go Parabolic in 2024

These innovation-oriented companies could take flight this year.

ABCL : 2.09 (unch)
CERS : 1.2400 (-3.88%)
TSHA : 1.2200 (-3.17%)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cerus: Q2 Earnings Snapshot

Cerus: Q2 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor keeps making moves.

COIN : 160.55 (-5.98%)
RKLB : 16.37 (-8.50%)
CERS : 1.2400 (-3.88%)
Cerus: Q1 Earnings Snapshot

Cerus: Q1 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cerus Corporation Announces First Quarter 2023 Financial Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2023.

CERS : 1.2400 (-3.88%)
Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023

Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2023 financial results will be released on Thursday, May 4, 2023, after the close of the stock market. The Company will host a conference...

CERS : 1.2400 (-3.88%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular growth investor publishes her daily transactions. Cathie Wood keeps buying Tesla as well as some of her smaller holdings.

TSLA : 239.43 (-10.42%)
CERS : 1.2400 (-3.88%)
HOOD : 34.51 (-9.80%)
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 1.2400 (-3.88%)
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and full year ended December 31, 2022.

CERS : 1.2400 (-3.88%)
Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full year 2022 financial results will be released on Tuesday, February 28, 2023, after the close of the stock market. The Company...

CERS : 1.2400 (-3.88%)
Cerus Corporation to Participate in Upcoming Investor Conferences

Cerus Corporation (Nasdaq: CERS) announced today that the Company will participate in two upcoming investor conferences.

CERS : 1.2400 (-3.88%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular growth investor publishes her daily transactions. She keeps buying Tesla as well as some low-priced genetics specialists.

TSLA : 239.43 (-10.42%)
CERS : 1.2400 (-3.88%)
NVTA : 0.0195 (+2.63%)

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 1.3733
2nd Resistance Point 1.3267
1st Resistance Point 1.2833
Last Price 1.2400
1st Support Level 1.1933
2nd Support Level 1.1467
3rd Support Level 1.1033

See More

52-Week High 2.5400
Fibonacci 61.8% 2.0243
Fibonacci 50% 1.8650
Fibonacci 38.2% 1.7057
Last Price 1.2400
52-Week Low 1.1900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades